Dentists in Moab, UT Accepting Medicare
7 Dentists found. Showing 1 - 7
 Christopher Flint, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2700 S Highway 191 Ste 1, Moab, UT 84532 Phone: 435-259-5378 |
Norman C Barber, D.M.D. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 380 North 500 West Suite 1, Moab, UT 84532 Phone: 435-259-4059 Fax: 435-259-9880 |
Dr. Jon Gordon Fuller Jr., D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 570 W 400 N, Moab, UT 84532 Phone: 435-259-4333 Fax: 435-259-6618 |
 Dr. Colleen Cornelius, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2700 S Highway 191, Ste. 1, Moab, UT 84532 Phone: 435-259-5378 Fax: 435-259-3458 |
Dr. Jeffery Cornelius, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2700 S Highway 191, Ste. 1, Moab, UT 84532 Phone: 435-259-5378 Fax: 435-259-3458 |
Gregory J Gorman, DMD Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 570 W. 400n., Moab, UT 84532 Phone: 435-259-4333 Fax: 435-259-6618 |
Merrill M. Hugentobler, D.D.S Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 757 N Main St, Moab, UT 84532 Phone: 435-259-7418 Fax: 435-259-4036 |
News Archive
Improved toxicology test method
Researchers at Oregon State University recently completed the largest animal study ever done in the field of toxicology, and the findings challenge some basic concepts about how to determine what level of a cancer-causing compound can be considered safe.
Vaginal progesterone reduces rate of preterm birth and neonatal complications
A team of investigators of the National Institutes of Health housed at the Detroit Medical Center (DMC) and Wayne State University (WSU) published today that performing a cervical ultrasound in all pregnant women and treating those with a short cervix with vaginal progesterone reduces the rate of preterm birth and neonatal complications.
Oncolytics Biotech invests in BCBC; purchases convertible shares in exchange for common shares
Oncolytics Biotech Inc. ("Oncolytics") announced today that it has made an investment in British Canadian Biosciences Corp. (BCBC), a privately held biotechnology company specializing in the development of peptides for the treatment of a variety of conditions, including cancer.
Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH
Novartis Pharmaceuticals Corporation will showcase more than one hundred and sixty presentations on data from its robust oncology portfolio at two key medical congresses this month, demonstrating significant advances for patients with cancers and hematological diseases.
› Verified 6 days ago
Counselors
Clinical Social Workers
Pharmacists
Dentists
Occupational Therapists
Psychologists